《中华人民共和国民营经济促进法》(以下简称《民营经济促进法》)与经修订的《保障中小企业款项支 付条例》分别于2025年5月20日、6月1日正式施行。另外，工信部等15部门于3月13日发布的《关于促进 中小企业提升合规意识加强合规管理的指导意见》及其他与民营企业发展紧密相关的重要法规、政策也 在今年先后出台。 正是在此背景下，中国企业联合会维护企业和企业家合法权益工作委员会(以下简称"中国企联维权工 委")和企业合规工作委员会(以下简称"中国企联合规工委")秘书处与大成工程与基础设施行业委员会(以 下简称"大成工程与基础设施行委会")、北京山东企业商会于6月20日在京举办了"《民营经济促进法》 的实施与民营企业合规和权益保护"研讨会。该研讨会由大成北京总所工程与基础设施行业组、北京山 东企业商会法律工作委员会承办，中国企联维权工委和合规工委、北京大成律师事务所、北京山东企业 商会、北京潍坊企业商会、北京建筑大学等机构的企业家、法律专家近四十人参加研讨。 图/会议现场 主题发言环节，分别由来自中国企联合规工委与维权工委、北京山东企业商会、北京潍坊企业商会的六 位代表发言。 图/袁华之 研讨会由中国企联维权工委副秘 ...

Core Viewpoint - The article discusses the resurgence of private enterprises in China, highlighting their importance in the market and the potential for growth amid a changing regulatory environment and technological advancements [1][2]. Group 1: Importance of Private Enterprises - The significance of the private sector has been recognized by high-level policymakers [2]. - The regulatory cycle for the private economy has eased, indicating a more favorable environment for growth [2]. - Private enterprises are leading China's ambition to "go global" [2]. Group 2: Financial Performance and Valuation - Since the low point in 2022, private enterprises have seen profits and return on equity (ROE) increase by 22% and 1.2 percentage points, respectively [2]. - Compared to their historical performance and state-owned enterprises, private companies are currently undervalued [2]. - The top ten leading companies, referred to as "Chinese Prominent 10," are expected to enhance their market dominance, similar to the "Mag 7" in the U.S. [2][4]. Group 3: Growth Projections - The selected ten companies are projected to achieve a profit growth rate of 17% over the next decade, with a 13% growth expected in the next two years [5]. - Despite macroeconomic challenges, these companies are expected to maintain double-digit profit growth [5]. Group 4: Market Dynamics and Opportunities - The market concentration of the top ten companies in China is only 17%, compared to 30% in the U.S., indicating potential for growth [4]. - The article emphasizes the importance of selecting individual stocks within the private sector, as there are significant differences in returns [6]. - Many of these companies are expanding their businesses overseas, particularly in emerging markets along the "Belt and Road" initiative [6]. Group 5: Sector Focus and IPO Trends - The consumer services sector is viewed as superior, with healthcare stocks gaining attention due to past regulatory challenges [7]. - Recent interest in Hong Kong IPOs is noted, with around 60 companies planning or applying for listings, presenting further investment opportunities [7].

长江商报消息 ●长江商报记者 徐靓丽 "全国向民间资本推介项目平台"数据显示，截至今年6月20日，全国向民间资本推介项目达11745个，总 投资额10.14万亿元。 多地发布重大项目清单 国家统计局日前发布的数据显示，随着一系列促进民营经济发展的政策措施落地实施，民间项目投资稳 定增长。1—5月份，民间投资同比持平。其中，民间项目投资（扣除房地产开发民间投资）同比增长 5.8%。分行业看，住宿和餐饮业民间投资增长25.3%，增速比1—4月份加快2.6个百分点；文化、体育和 娱乐业民间投资增长10.0%，增速加快2.1个百分点；基础设施民间投资增长10.0%，增速加快0.4个百分 点；制造业民间投资增长8.1%。 2025年以来，多地持续面向民间资本推介投资项目清单，鼓励和吸引民间资本参与重大项目建设。湖北 省发展改革委发布的2025年第一批面向民间资本的投资项目清单，229个项目入选，计划引入民间资本 916.7亿元，涉及光电子、新材料等重点产业领域。山西省发布的2025年第一批向民间资本推介项目名 单，共有项目60个，计划总投资622亿元，计划引入民间资本227亿元，包含产业类项目（含重点产业链 供应链项目 ...

为强化贯彻实施，保障民营经济促进法落地见效，通知要求，加快完善配套制度，对照法律规定做 好立改废释；全面落实法律规定，增强法治意识，履行法定职责，严格按照法定职权和程序开展工作， 积极协调解决民营经济发展中的重大问题，依法维护民营企业和民营企业家合法权益；强化行政执法监 督，以规范涉企行政执法专项行动为切入点，进一步健全涉企行政执法诉求沟通机制，及时受理并依法 处理投诉举报，着力纠治违反民营经济促进法等法律法规的行政执法突出问题；优化法律服务供给，持 续开展行政复议护航民营企业高质量发展等活动，加强行业性、专业性人民调解组织建设，稳步推进商 事调解试点工作，帮助民营企业及时解决经营发展中遇到的矛盾纠纷。 "我们要求各地各部门全面落实'谁执法谁普法、谁管理谁普法、谁服务谁普法'普法责任制，把学 习宣传活动开展情况记入年度普法工作台账，强化协同联动，创新方式方法，确保学习宣传贯彻工作扎 实开展。"省委依法治省办相关负责人表示。（记者：陶玉琼） 按照通知要求，陕西将加大普法力度。领导干部带头学，把民营经济促进法列入党委（党组）中心 组年度学习计划，通过组织专题学习和集体学习等方式，推动各级领导干部和国家机关工作人员 ...

中新网郑州6月22日电(阚力王佳宁)21日在河南郑州举行的第四届河南高质量发展高层论坛暨民营经济 高质量发展研讨会上，多位经济专家为民营企业开"出海良方"。 由郑州大学主办的此次会议，与会专家学者围绕新阶段民营经济高质量发展的重点难点、民营企业治理 结构和管理制度创新、民营企业出海等议题展开讨论。 在民营企业出海方面，与会专家建议，应强化完善企业出海链条，在海外布局"豫品展销中心"，并建立 跨境供应链联盟，整合中欧班列、海外仓资源，降低企业出海物流成本，使民营企业的出海通道更宽 广、平坦。 "为企业出海强链补链，这些是必须要考虑的问题。"郑州大学商学院副教授王磊玲表示，设立海外"豫 品展销中心"，可以为企业打开一扇展示交流的窗口，让产品直面国际市场，更便捷地接触到全球消费 者。而建立跨境供应链联盟不仅能够解决跨境企业物流成本居高不下的"痛点"，而且通过各方资源整 合，可以实现信息共享、风险共担，提升跨境供应链的稳定性，进而提高企业在国际市场上的竞争力。 在与会企业家北京爱跨境数字科技有限公司董事长刘向阳看来，如今，越来越多的民营企业选择出海， 发展势头也越来越好。 河南省统计局数据显示，今年一季度，河南民营企 ...

另一方面，以诚信守法为底线，构建企业内部源头防范和治理腐败体制机制，增强预警识别能力，加强 廉洁风险防控，特别是规范会计核算、防止财务造假等。从实践看，民营企业在面对内部人员犯罪问题 时，难于取证和界定，常常作内部处理，导致腐败隐患难以消除。对此，企业当以"壮士断腕"之决心， 将"害群之马"绳之以法。 法治是最好的营商环境。当前，各地各部门正积极推进贯彻落实民营经济促进法。筑牢民营企业内部反 腐防线，更要严格规范执法，持续优化营商环境，依法平等保护促进民营经济发展，让企业在阳光下安 心经营、稳健前行。 （文章来源：经济日报） 民营企业工作人员腐败犯罪行为表现形式多样。有的发生在"关键少数""重要岗位"，如在燕某、孙某非 国家工作人员受贿案中，两被告人作为某控股公司董事，收受贿赂高达5.6亿余元；有的发生在互联网 企业，如石某玉非国家工作人员受贿、职务侵占案中，被告人作为某互联网企业工作人员，通过将虚拟 币变现的方式侵占公司财物366万元；有的则是内部工作人员"说转就转"，挪用企业资金归个人使用， 带来重大隐患。职务行为引发的腐败犹如"蛀虫"，不仅侵蚀企业生命力，制约企业发展壮大，严重者还 将影响行业生态，扰乱 ...

Core Viewpoint - The sudden resignation of Xiao Wei as the chairman of Kangyuan Pharmaceutical raises questions about the company's future direction amid declining performance [1][3]. Group 1: Leadership Changes - Xiao Wei has resigned as the chairman of Kangyuan Pharmaceutical but will continue to serve as a director and hold other committee positions [3]. - He has been the chairman since November 2000 and is recognized as the founder and actual controller of the company [3][4]. - The company will soon complete the election of a new chairman, and Xiao Wei's resignation does not affect the board's operational capacity [3]. Group 2: Financial Performance - In 2024, Kangyuan Pharmaceutical reported a revenue of 3.898 billion yuan, a year-on-year decrease of 19.86%, and a net profit of 392 million yuan, down 15.58% [6][7]. - The downward trend continued into the first quarter of 2025, with revenue declining by 35.38% and net profit decreasing by 38.37% year-on-year [7]. - The company has faced challenges in meeting performance targets, leading to the cancellation of stock incentive plans for 155 employees [7][8]. Group 3: Market Context - The company focuses on traditional Chinese medicine, particularly in areas such as respiratory and cardiovascular diseases, and is also expanding into biopharmaceuticals [6]. - There has been a trend of state-owned enterprises acquiring private Chinese medicine companies, indicating a shift in the industry landscape [8][10]. - As of June 20, Kangyuan Pharmaceutical's stock closed at 14.73 yuan per share, with a market capitalization of 8.34 billion yuan [11].

Core Viewpoint - The sudden resignation of Xiao Wei as the chairman of Kangyuan Pharmaceutical raises questions about the company's future direction amid declining performance [2][5]. Group 1: Company Leadership Changes - Xiao Wei, the founder and actual controller of Kangyuan Pharmaceutical, has resigned as chairman but will continue to serve as a board member and in other roles [2][5]. - His resignation is attributed to personal reasons, and it is stated that it will not affect the normal operation of the board [5][6]. - Xiao Wei has been a significant figure in the company since its inception, leading its transformation towards modernization and innovation [5][6]. Group 2: Financial Performance - In 2024, Kangyuan Pharmaceutical experienced a significant decline in performance, with revenue dropping by 19.86% to 3.898 billion yuan and net profit decreasing by 15.58% to 392 million yuan [3][8]. - The downward trend continued into the first quarter of 2025, with revenue falling by 35.38% and net profit declining by 38.37% compared to the previous year [3][8]. Group 3: Stock Incentive Plan - Due to unmet performance targets for 2024, Kangyuan Pharmaceutical decided to repurchase and cancel 3.3003 million shares of restricted stock from 155 incentive plan participants [9]. Group 4: Industry Context - There has been a trend of state-owned enterprises acquiring private traditional Chinese medicine companies, with several recent examples [10][11]. - The stock price of Kangyuan Pharmaceutical was reported at 14.73 yuan per share, with a market capitalization of 8.34 billion yuan as of June 20 [13].

Group 1 - The event titled "Capital Market Servicing High-Quality Development of Private Economy in Ningbo" was held to promote the implementation of the new "National Nine Articles" and to enhance the capital market's role in supporting private economic development [1] - 11 industry institutions and 8 representatives from private enterprises participated, sharing experiences on direct financing, corporate governance, and risk management [1][2] - Yongxing Securities, as the only local securities firm in Ningbo, has completed 19 investment banking projects since its establishment in 2020, with a total financing scale of 14.362 billion yuan [1] Group 2 - Representatives from various securities firms expressed their commitment to support Ningbo's private economy and proposed strategies for enhancing service delivery [2] - Companies like Hengshuai Co., Ltd. shared their experiences with capital market tools, including the successful issuance of convertible bonds, focusing on projects in automotive micro-motors and cleaning systems [3] - Legal experts emphasized the importance of providing high-quality legal services to private enterprises, highlighting the need for compliance, governance, and digital transformation support [4]

据了解，针对企业科技研发的实际情况，新泰市税务局依托税收大数据，构建全流程动态风险监控体 系，通过采集企业申报、开票、资金流等数据指标，建立行业化管理指标模型，采用提前介入等方式， 强化研发费用归集辅导，帮助企业厘清政策口径，了解研发费用归集偏差、优惠政策适用错误可能遇到 的风险，助力企业准确、高效地享受税费优惠政策。 目前，民营经济主体正成为创新的主力军，在他们勇于创新的同时，守法合规经营成为了民营经济行稳 致远的"必答题"。"做生意就是要以诚信为本！纳税信用好，不仅在办税缴费的过程中可以获得更多的 便利，也让我们赢得了更多客户的信任，成为公司招揽合作对象的'金字招牌'！"山东长宇新材料有限 公司财务负责人张英说。 山东长宇新材料有限公司是一家致力于研发生产真空蒸镀柔性材料的企业，是省级制造业单项冠军，产 品远销越南、印度、韩国、澳大利亚等国家。作为深耕材料行业十余年的企业，要想持续提升出口竞争 力，就要在产品创新上下功夫，而加强产品创新，资金投入很关键。"2024年以来，我们凭借良好的纳 税信用，已经通过'快审快办'绿色通道办理出口退税270多万元，并将这些资金用于升级改造配套冷却 系统和分切设备，对提升 ...